Frequency of TERT promoter mutations in human cancers

Vinagre, João, Almeida, Ana, Pópulo, Helena, Batista, Rui, Lyra, Joana, Pinto, Vasco, Coelho, Ricardo, Celestino, Ricardo +16 more·2013·Nature Communications
DOI 10.1038/ncomms3185

Cited by (886)

Items 801–886 of 886

  1. Kongenitales Knochenmarkversagen
    Christian Peter Kratz, Helmut Hanenberg · 2014 · Monatsschrift Kinderheilkunde
  2. Tumour mutations in long noncoding RNAs enhance cell fitness
    Roberta Esposito, Andrés Lanzós, Taisia Polidori, Hugo Guillen-Ramirez, Bernard Mefi Merlin, Lia Mela, Eugenio Zoni, Isabel Büchi, Lusine Hovhannisyan, Finn McCluggage et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  3. An Agent-based Paradigm for Allocating Multi-Provider Service Demands.
    Monique Calisti, Boi V. Faltings · 2000
  4. Un triunfador Lefebvre
    Joaquim Gomis · 1987 · El Ciervo: revista mensual de pensamiento y cultura
  5. Mutação do promotor TERT no carcinoma anaplásico da tireoide: um relato de caso
    Rafael Reis Campos da Matta, Helton Estrela Ramos · 2021 · Revista de Ciências Médicas e Biológicas
  6. Structural characterization and selective drug targeting of higher-order DNA G-quadruplex systems.
    Robert C. Monsen · 2020
  7. Biomarkers in Endocrine Organ Carcinomas
    Yasemin Sahin, Merih Güray Durak, Özgür Mete · 2022 · Springer eBooks
  8. Telomere maintenance and genome stability
    Wei Huang, Wilnelly M. Hernandez-Sanchez, Mengyuan Xu, Derek J. Taylor · 2021 · Elsevier eBooks
  9. Telomerase in hepatocellular carcinoma
    Radhika Tippani, Kalam Sirisha, Srinivas Podeti, Mahendar Porika · 2022 · Elsevier eBooks
  10. Precision medicine for granulosa cell tumors of the ovary
    Joline F. Roze · 2022
  11. Faculty Opinions recommendation of A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers.
    Colin A M Semple · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  12. Editorial on “The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma”
    Rui Batısta, Tiago Bordeira Gaspar, Paula Soares, João Vinagre · 2018 · Translational Cancer Research
  13. Faculty Opinions recommendation of Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk.
    Chao Cheng · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  14. Therapeutic Options
    Miguel Melo, José Cameselle‐Teijeiro, Catarina Eloy, Isabel Amendoeira, Paula Soares, Javier Caneiro-Gómez, Manuel A. Sobrinho-Simões · 2017 · Springer eBooks
  15. TERT Mutation was Associated with the Risk of Recurrence in Lung Adenocarcinoma with A Micropapillary Pattern
    Fenfang Wang, Lu Xu, Qing Hao, Chenghui Li, Qihuan Wu, Hongyang Lu · 2020
  16. Identification of h-TERT Promoter Mutations in Germline DNA from North Indian Lung Carcinoma Patients
    Rajendra Prasad, Sonia Panchal, Isha Rani, Jai Kishan, Gaurav Parashar · 2022 · Indian Journal of Clinical Biochemistry
  17. Marcatori genetici di aggressività nel carcinoma papillare della tiroide (PTC)
    Benedetta Donati, Federica Torricelli, Alessia Ciarrocchi · 2022 · L Endocrinologo
  18. Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications
    Valeria Internò, Giacomo Triggiano, Pierluigi De Santis, Luigia Stefania Stucci, Marco Tucci, Camillo Porta · 2022 · Frontiers in Oncology
  19. Telomerase Reverse Transcriptase in Humans: From Biology to Cancer Immunity
    Magalie Dosset, Andrea Castro, Xian Su, Hannah K. Carter, Maurizio Zanetti · 2022 · Interdisciplinary cancer research
  20. Revana: a comprehensive tool for regulatory variant analysis and visualization of cancer genomes
    Elias Ulrich, Stefan Michael Pfister, Natalie Jäger · 2022 · Bioinformatics
  21. Avaliação da biologia telomérica na tumorigênese dos craniofaringiomas
    José Ítalo Soares Mota · 2022 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  22. E4F1 and ZNF148 are transcriptional activators of the A57C and wildtype TERT promoter
    Boon Haow Chua, Laure Ferry, Cécilia Domrane, Nurkaiyisah Zaal Anuar, Anna Wittek, Sudhakar Jha, Falk Butter, Daniel Geoffrey Tenen, Pierre‐Antoine Defossez, Dennis Kappei · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Cross-talk between NF-κB and telomerase in cancer: Implications in therapy
    Shrey Madeka, Ekta Khattar · 2023 · Elsevier eBooks
  24. Data from Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors
    James R. Hawley, Stanley Zhou, Christopher Arlidge, Giacomo Grillo, Ken J. Kron, Rupert Hugh-White, Theodorus van der Kwast, Michael E. Fraser, Paul Christopher Boutros, Robert Glen Bristow et al. · 2023
  25. Supplementary Data from Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors
    James R. Hawley, Stanley Zhou, Christopher Arlidge, Giacomo Grillo, Ken J. Kron, Rupert Hugh-White, Theodorus van der Kwast, Michael E. Fraser, Paul Christopher Boutros, Robert Glen Bristow et al. · 2023
  26. Supplementary Table 2 from Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors
    James R. Hawley, Stanley Zhou, Christopher Arlidge, Giacomo Grillo, Ken J. Kron, Rupert Hugh-White, Theodorus van der Kwast, Michael E. Fraser, Paul Christopher Boutros, Robert Glen Bristow et al. · 2023
  27. Melanoma Clinicopathology
    Jean‐Jacques Grob, Caroline Gaudy‐Marqueste · 2024 · Wiley eBooks
  28. Additional file 2 of NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis
    Zhang, Jing, Jason J. Liu, Patrick D. McGillivray, Caroline Yi, Lucas Lochovsky, Donghoon Lee, Mark Gerstein · 2020 · Figshare
  29. Differential Gene Expression Analysis Supports Dysregulation of Mitochondrial Activity as a New Perspective for Glioblastoma's Aggressiveness
    Ricardo Cunha de Oliveira, Felipe Gouvêa de Souza, Ana Gabrielle Bispo, Matheus Caetano Epifane-de-Assunção, Giovanna C. Cavalcante · 2024 · SSRN Electronic Journal
  30. Differential Gene Expression Analysis Supports Dysregulation of Mitochondrial Activity as a New Perspective for Glioblastoma's Aggressiveness
    Ricardo Cunha de Oliveira, Felipe Gouvêa de Souza, Ana Gabrielle Bispo, Matheus Caetano Epifane-de-Assunção, Giovanna C. Cavalcante · 2024 · SSRN Electronic Journal
  31. Telomeres and Cancer
    Arturo Londoño‐Vallejo · 2024 · Wiley eBooks
  32. Telomere Maintenance Mechanisms in Cancer
    Tito T. Jesus, Rui Sousa Martins, Tiago Bordeira Gaspar, Paula Soares, João Vinagre · 2024 · Interdisciplinary cancer research
  33. Are TERT Promoter Mutations a Poor Prognostic Factor in Anaplastic Thyroid Carcinoma?
    Hyun Jin Ryu, Young Lyun Oh, Jung Heo, Hyunju Park, Tae Hyuk Kim, Sun Wook Kim, Jae Hoon Chung · 2024 · International Journal of Thyroidology
  34. Systematic identification of context-dependent gene-essentiality in Glioblastoma: The GBM-CoDE platform
    Mitchell T. Foster, Ailith Ewing, Margaret C. Frame, Paul Martin Brennan, Ava Khamseh, Sjoerd Viktor Beentjes, Neil O. Carragher, Colin A M Semple · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  35. SPP1A and VEGFC splice isoforms as predictive diagnostic biomarkers for high and low-grade bladder cancer
    Akram Mirzaei · 2025 · American Journal of Clinical and Experimental Urology
  36. Levels of telomerase in cancer are contingent on senescence and inflammation at bulk tissue and single-cell spatial resolution
    Nighat Noureen, Min Hee Kang · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  37. SNAI2 cooperates with MEK1/2 and HDACs to suppress BIM- and BMF-dependent apoptosis in TERT promoter mutant cancers
    Amol Tandon, Josh Lewis Stern · 2025 · PLoS ONE
  38. TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis
    Abdou Malik Da Silva, Zofia Hélias‐Rodzewicz, Irena Antonia Ungureanu, Jean‐François Emile · 2025 · Cancer Medicine
  39. A core driver gene set identified based on geMER reveals its potential driver mechanism in pan-cancer
    Jing Gan, Yuncong Wang, Zhuoran Shi, Haoyu Hu, Manyi Xu, Xinrong Li, Wenbo Dong, Jia He, Yusen Zhao, Yakun Zhang et al. · 2025 · npj Precision Oncology
  40. Molecular Alterations in Thyroid Tumors
    2025 · American Registry of PathologyArlington, Virginia eBooks
  41. TERT promoter mutations in meningiomas: associations with clinicopathological features and insights into spatial and temporal heterogeneity in a 165-case cohort
    Ahmet Boduroğlu, Mualla Özcan, Güzide Ayşe Ocak · 2025 · Pathology - Research and Practice
  42. The investigation of new mutations in telomerase reverse transcriptase promoter region in association with bladder cancer
    Hanan H. Ramadhan, Safaa Abdulabass Alhamedi, Ammar Ihsan Awadh, Omar F. Abdul‐Rasheed, Safaa Gatea Mezban · 2025 · Journal of Research in Pharmacy
  43. Prognostic Implications of Acquired Genetic Changes in Uveal Melanoma
    Anna E. Koopmans · 2015 · EUR Research Repository (Erasmus University Rotterdam)
  44. Additional file 1 of NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis
    Zhang, Jing, Jason J. Liu, Patrick D. McGillivray, Caroline Yi, Lucas Lochovsky, Lee, Donghoon, Mark Gerstein · 2020 · Figshare
  45. Additional file 13 of THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
    Apolónio, Joana Dias, João S. Dias, Mónica Teotónio Fernandes, Martin Komosa, Tatiana Lipman, Cindy H. Zhang, Leão, Ricardo, Donghyun D. Lee, Nuno Miguel Nunes, Maia, Ana-Teresa et al. · 2023 · Figshare
  46. Additional file 2 of Development of super-specific epigenome editing by targeted allele-specific DNA methylation
    Nivethika Rajaram, Alexandra G. Kouroukli, Susanne Bens, Pavel Bashtrykov, Albert Jeltsch · 2024 · Figshare
  47. Additional file 14 of THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
    Apolónio, Joana Dias, João S. Dias, Mónica Teotónio Fernandes, Martin Komosa, Tatiana Lipman, Cindy H. Zhang, Leão, Ricardo, Lee, Donghyun, Nuno Miguel Nunes, Maia, Ana-Teresa et al. · 2023 · Figshare
  48. Additional file 1 of The telomere maintenance mechanism spectrum and its dynamics in gliomas
    Kim, Sojin, Tamrin Chowdhury, Hyeon Jong Yu, Jee Ye Kahng, Chae Eun Lee, Choi, Seung Ah., Kim, Kyung-Min, Ho Kang, Lee, Joo Ho, Lee, Soon-Tae et al. · 2022 · Figshare
  49. Additional file 12 of THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
    Apolónio, Joana Dias, João S. Dias, Mónica Teotónio Fernandes, Martin Komosa, Tatiana Lipman, Cindy H. Zhang, Leão, Ricardo, Donghyun D. Lee, Nunes, Nuno Miguel, Maia, Ana-Teresa et al. · 2023 · Figshare
  50. Additional file 3 of Development of super-specific epigenome editing by targeted allele-specific DNA methylation
    Nivethika Rajaram, Alexandra G. Kouroukli, Susanne Bens, Pavel Bashtrykov, Albert Jeltsch · 2024 · Figshare
  51. Additional file 1 of Targeting oncogenic TERT promoter variants by allele-specific epigenome editing
    Alexandra G. Kouroukli, Nivethika Rajaram, Pavel Bashtrykov, Helene Kretzmer, Siebert, Reiner, Albert Jeltsch, Susanne Bens · 2023 · Figshare
  52. Additional file 1 of Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
    Maxime Fontanilles, Marguet, Florent, Ludivine Beaussire, Nicolas Magné, Pépin, Louis-Ferdinand, Cristina Alexandru, Isabelle Tennevet, C. Hanzen, Olivier Langlois, Fabrice Jardin et al. · 2020 · Figshare
  53. Additional file 1 of Development of super-specific epigenome editing by targeted allele-specific DNA methylation
    Nivethika Rajaram, Alexandra G. Kouroukli, Susanne Bens, Pavel Bashtrykov, Albert Jeltsch · 2024 · Figshare
  54. High-sensitivity Approach for Detection of Tert Promoter Variants in Shh-activated Pediatric Medulloblastomas
    Laura Giunti, Milena Guidi, Valentina Cetica, Abramo Ponticelli, Mirko Scagnet, Federico Mussa, Flavio Giordano, Rina Agushi, Lorenzo Genitori, Iacopo Sardi et al. · 2026 · Research Square
  55. Insights into telomerase activity in bladder cancer pathology
    Aleksandra Binda, Maciej Skrzypek, Ireneusz Majsterek, Tomasz Konecki · 2026 · Archives of Medical Science
  56. Relationship between genetically determined telomere length and childhood glioma risk
    Naying Zhou, Shaobo Li, Jon Foss-Skiftesvik, Anna M. Dahlin, Jonas Bybjerg‐Grauholm, Beatrice Melin, Adam J. de Smith, Kyle M. Walsh, Joseph Leo Wiemels · 2026 · Acta Neuropathologica Communications
  57. Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus
    Aidan O’Brien, Hyunkyung Kong, Harsh Patel, Michelle Ho, Minal B. Patel, Jun Zhong, Mai Xu, Brenen W. Papenberg, Katelyn E. Connelly, Irene J. Collins et al. · 2026 · medRxiv
  58. An overview of molecular genetics of brain tumors
    Brian J. Scott, Santosh Kesari · 2026 · Elsevier eBooks
  59. がん細胞多層オーミクス統合ネットワーク解析による遺伝子発現制御領域塩基変異の機能解析
    Sarun Sereewattanawoot · 2020 · Institutional Repositories DataBase (IRDB)
  60. Etude de l'instabilité génomique et du statut des télomères dans le cancer du sein.
    Mathilde Gay‐Bellile · 2017 · theses.fr (ABES)
  61. A la recherche des effets de l'inactivation génétique d'ATRX dans le déclenchement de la voit ALT (télomérase-indépendante) de maintenance des télomères dans les cellules cancéreuses
    Rita Eid · 2015 · theses.fr (ABES)
  62. Génomique intégrée des neuroblastomes olfactifs : implications anatomopathologiques et thérapeutiques
    Marion Classe · 2017 · theses.fr (ABES)
  63. Génétique et évolution clonale des syndromes d’insuffisance médullaire
    Marie Sébert · 2018 · theses.fr (ABES)
  64. Using the systematic nature of errors in NGS data to efficiently detect mutations : computational methods and application to early cancer detection
    Tiffany Myriam Delhomme · 2019 · theses.fr (ABES)
  65. Régulation épigénétique de la télomérase dans un modèle de leucémie aiguë promyélocytaire
    Delphine Garsuault · 2019 · theses.fr (ABES)
  66. Maintenance télomérique : intérêt dans le diagnostic des gliomes en lien avec le métabolisme mitochondrial
    Pauline Billard · 2021 · theses.fr (ABES)
  67. Validation de modèles 3D de chordome et preuves de concept in vitro d’une stratégie radiosensibilisante
    Marie-Anaïs Locquet · 2021 · theses.fr (ABES)
  68. Weakly Supervised Segmentation and Context-Aware Classification in Computational Pathology
    Marvin Lerousseau · 2022 · theses.fr (ABES)
  69. Régulation de la chromatine par SMCHD1 : implication dans la dystrophie facio-scapulo-humérale et le syndrome d'arhinie et de microphtalmie de Bosma
    Camille Laberthonnìère · 2021 · theses.fr (ABES)
  70. Nouvelles approches de prédiction de la pathogénicité des mutations
    Mélanie Corcuff · 2022 · theses.fr (ABES)
  71. Méthode d'apprentissage profond pour l'analyse génomique des cancers canins comme modèle des cancers humains
    Camille Kergal · 2022 · theses.fr (ABES)
  72. Genomic and mutational landscape of anaplastic ependymoma: Insights from the AACR Project GENIE Consortium
    Edie Gobel, Grace S. Saglimbeni, Iosef I. Perez, BHANU SURABI UPADHYAYULA, T C M Morris, Akaash Surendra, Beau Hsia, Abubakar Tauseef · 2026 · Biomolecules and Biomedicine
  73. hTERT Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma
    Ryuma Tanaka, Banlanjo Abdulaziz Umaru, Matthew Sobo, Shiva Senthil Kumar, Kathleen McCarthy O'Toole Dorris, Volker Hovestadt, Vijay Ramaswamy, Marc Remke, Ashley Margol, Charles B. Stevenson et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Impact of Cholecystectomy on Gastric Mucosal c-MYC and h-TERT Expression; A Potential Link to Gastric Cancer Development
    E Kasap, Seda Sabah Özcan, L Elmas, F Seher Ozalp Ates, M Korkmaz · 2025 · Balkan Journal of Medical Genetics
  75. ARMS‐qPCR‐Based Detection of BRAF and TERT Promoter Mutations: A Cost‐Effective Strategy for Molecular Diagnosis of Papillary Thyroid Carcinoma
    Yuanyuan Jia, ZHANG Yajun, Dandan Sun, Jiabao Yang, Mengshi Zhou, Min Gao, Rui Li · 2026 · International Journal of Endocrinology
  76. Predicting progression-free survival in glioblastoma with neuroimaging and machine learning
    Davin Hickman-Chow, Patrick H. Luckett, Michael O. Olufawo, Donna L. Dierker, Joshua S. Shimony, Eric C. Leuthardt · 2026 · Journal of Neuro-Oncology
  77. Cytologic and Surgical Correlation of TERT -Mutated Indeterminate Thyroid Nodules: A Case Series
    Saroja Devi Geetha, Neha Seth, Karen Chau, Kasturi Das · 2026 · International Journal of Surgical Pathology
  78. Spinal low-grade ependymal tumors harboring telomerase reverse transcriptase promoter mutation and chromosome 7 gain with methylation profile of spinal subependymoma
    Yoshitaka Nagashima, Junya Yamaguchi, Yusuke Nishimura, Masafumi Seki, Seiji Yamada, Sachi Maeda, Eisuke Tsukamoto, Ryo Yamamoto, Yuhei Takido, Keisuke Kimura et al. · 2026 · Acta Neuropathologica Communications
  79. Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan
    Saya Kaidarova, Zhanna Mussazhanova, Zhanna Kozykenova, Hirokazu Kurohama, Akbota Targynova, Altay Dyussupov, Zhanar Yeleubayeva, Masahiro Nakashima · 2026 · PLoS ONE
  80. Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level
    Anu Singh, Aroonima Misra, Sufian Zaheer · 2026 · Aging and Cancer
  81. TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma
    Vicente Rodrigues Marczyk, Sophie Li, Chia-Chin Wu, Matthew A. Loberg, Ying C. Henderson, Meghan Martin, Sarah Hamidi, Steven Gerard Waguespack, Naifa Lamki Busaidy, Ramona Dadu et al. · 2026 · JAMA Otolaryngology–Head & Neck Surgery
  82. FOXE1, IMP-3, and TERT expressions in papillary thyroid carcinomas
    Nurtaç Asa Sarıkaş, Nuray Can, Necdet Süt, Yavuz Atakan Sezer, Buket Yılmaz Bülbül, Ebru Tastekin, Ufuk Usta, Fulya Öz Puyan, T. Deniz Yalta, Funda Üstün · 2026 · Indian Journal of Pathology and Microbiology
  83. Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations
    Xianzhao Deng, Mengyue Liu, Chen-Tian Shen, Hong-Jun Song, Jian Wang, You-Ben Fan, Quan-Yong Luo, Tang Juan, Xiao-er Wei, Zhong‐Ling Qiu · 2026 · Frontiers in Oncology
  84. Malignant phyllodes tumour with spinal metastasis presenting as cauda equina syndrome
    Osman Mahboob, Yujin Suk, Mona Bishara, Gemah Moammer · 2026 · BMJ Case Reports
  85. RET Variant Reclassification across Demographic Sub-Groups in a Large-Scale Clinical Population
    Kirkpatrick B. Fergus, Marcy E. Richardson, Elad Ziv, Julie Ann Sosa, Elizabeth Gardner Grubbs · 2026 · Thyroid
  86. DNA damage
    Barry S. Rosenstein, Jerome M. Karp · 2026 · Elsevier eBooks